These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12200903)

  • 1. Characteristic profile of intestinal microflora in Kawasaki disease.
    Takeshita S; Kobayashi I; Kawamura Y; Tokutomi T; Sekine I
    Acta Paediatr; 2002; 91(7):783-8. PubMed ID: 12200903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tendency toward atopy in Kawasaki disease.
    Matsuoka S; Tatara K; Nakagawa R; Mori K; Kuroda Y
    Eur J Pediatr; 1997 Jan; 156(1):30-2. PubMed ID: 9007486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative incidence of Kawasaki disease in Japan.
    Nakamura Y; Yashiro M; Yamashita M; Aoyama N; Otaki U; Ozeki Y; Sano T; Kojo T; Ae R; Aoyama Y; Makino N; Kotani K
    Pediatr Int; 2018 Jan; 60(1):19-22. PubMed ID: 29095541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease: A brief history.
    Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
    Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiologic studies on the small intestine in Kawasaki disease.
    Yamashiro Y; Nagata S; Ohtsuka Y; Oguchi S; Shimizu T
    Pediatr Res; 1996 Apr; 39(4 Pt 1):622-4. PubMed ID: 8848335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of febrile convulsion during the acute phase of Kawasaki disease in Japan.
    Nozaki H; Matsubara K; Fukaya T; Iwata A; Harigaya H; Nigami H; Baba K
    Eur J Pediatr; 2005 Oct; 164(10):650. PubMed ID: 16010561
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
    BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological observations of Kawasaki disease in Japan, 2013-2014.
    Makino N; Nakamura Y; Yashiro M; Sano T; Ae R; Kosami K; Kojo T; Aoyama Y; Kotani K; Yanagawa H
    Pediatr Int; 2018 Jun; 60(6):581-587. PubMed ID: 29498791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012.
    Sano T; Makino N; Aoyama Y; Ae R; Kojo T; Kotani K; Nakamura Y; Yanagawa H
    Pediatr Int; 2016 Nov; 58(11):1140-1145. PubMed ID: 26940079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.
    Makino N; Nakamura Y; Yashiro M; Kosami K; Matsubara Y; Ae R; Aoyama Y; Yanagawa H
    Pediatr Int; 2019 Apr; 61(4):397-403. PubMed ID: 30786118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Kawasaki Disease Incidence Associated With Higher Precipitation and Lower Temperatures, Japan, 1991-2004.
    Abrams JY; Blase JL; Belay ED; Uehara R; Maddox RA; Schonberger LB; Nakamura Y
    Pediatr Infect Dis J; 2018 Jun; 37(6):526-530. PubMed ID: 29140936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki disease before kawasaki at Tokyo university hospital.
    Shibuya N; Shibuya K; Kato H; Yanagisawa M
    Pediatrics; 2002 Aug; 110(2 Pt 1):e17. PubMed ID: 12165616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
    Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
    J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.
    Makino N; Nakamura Y; Yashiro M; Ae R; Tsuboi S; Aoyama Y; Kojo T; Uehara R; Kotani K; Yanagawa H
    J Epidemiol; 2015; 25(3):239-45. PubMed ID: 25716368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.
    Hirata S; Nakamura Y; Yanagawa H
    Acta Paediatr; 2001 Jan; 90(1):40-4. PubMed ID: 11227331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease.
    Takeshita S; Kawamura Y; Takabayashi H; Yoshida N; Nonoyama S
    Clin Exp Immunol; 2005 Mar; 139(3):575-9. PubMed ID: 15730405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002.
    Chang LY; Chang IS; Lu CY; Chiang BL; Lee CY; Chen PJ; Wang JT; Ho HN; Chen DS; Huang LM;
    Pediatrics; 2004 Dec; 114(6):e678-82. PubMed ID: 15574600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
    Kawasaki T
    Acta Pathol Jpn; 1982; 32 Suppl 1():63-72. PubMed ID: 7187577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999.
    Du ZD; Zhang T; Liang L; Meng X; Li T; Kawasaki T; Nakamura Y; Yanagawa H
    Pediatr Infect Dis J; 2002 Feb; 21(2):103-7. PubMed ID: 11840075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Kawasaki disease: USA and Japan.
    Maddox RA; Holman RC; Uehara R; Callinan LS; Guest JL; Schonberger LB; Nakamura Y; Yashiro M; Belay ED
    Pediatr Int; 2015 Dec; 57(6):1116-20. PubMed ID: 26096590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.